Compare VYGR & HWBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VYGR | HWBK |
|---|---|---|
| Founded | 2013 | 1865 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.0M | 228.8M |
| IPO Year | 2015 | 1996 |
| Metric | VYGR | HWBK |
|---|---|---|
| Price | $3.74 | $32.66 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $21.00 | N/A |
| AVG Volume (30 Days) | ★ 862.4K | 3.1K |
| Earning Date | 03-09-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 2.58% |
| EPS Growth | N/A | ★ 31.42 |
| EPS | N/A | ★ 3.43 |
| Revenue | ★ $10,135,000.00 | N/A |
| Revenue This Year | $54.19 | N/A |
| Revenue Next Year | $20.22 | N/A |
| P/E Ratio | ★ N/A | $9.50 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.65 | $25.50 |
| 52 Week High | $5.55 | $36.25 |
| Indicator | VYGR | HWBK |
|---|---|---|
| Relative Strength Index (RSI) | 42.89 | 43.13 |
| Support Level | $3.36 | $32.33 |
| Resistance Level | $3.74 | $33.71 |
| Average True Range (ATR) | 0.32 | 0.87 |
| MACD | -0.06 | -0.10 |
| Stochastic Oscillator | 4.87 | 12.89 |
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
Hawthorn Bancshares Inc is a financial holding company that, along with its subsidiary bank, provides commercial banking for small and mid-sized businesses, including equipment, operating, commercial real estate and SBA loans, and personal banking services such as real estate mortgage lending, installment and consumer loans, certificates of deposit, checking, savings and money market accounts. The company also provides trust services including estate planning, investment and asset management services, brokerage and cash management services. Its primary source of revenue is net interest income derived from lending and deposit taking activities, with much of its business in commercial, commercial real estate development and residential mortgage lending.